Boostrix tdap vaccine syringe 0.5ML
Ended Awarded
- Contract number
- SPE2DB25FP6YZ
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,989
Award facts
- Contract value 100% obligated
- $1,988.98 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,988.98 to DMS Pharmaceutical Group Inc. on June 3, 2025, with an ultimate completion date of June 4, 2025. The delivery order is for Boostrix TDAP vaccine syringes in 0.5mL dosages, to be delivered to Park Ridge, Illinois. This contract utilizes a firm fixed-price structure with no set-aside designation. The award represents a single delivery order issued under DMS Pharmaceutical Group's existing Indefinite Delivery Contract with the DLA, valued at approximately $500 million through November 2026, which authorizes the agency to procure a comprehensive range of pharmaceutical products and medical supplies supporting Department of Defense healthcare facilities.
DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, and has been registered in the System for Award Management (SAM.gov) since 2001. The company specializes in distributing branded and generic prescription drugs, biologics, vaccines, and medical consumables to federal healthcare systems, with a robust portfolio of prior contract awards through the DLA. This delivery order for TDAP vaccine syringes aligns with the contractor's core business of providing essential pharmaceutical products and vaccines to military health facilities nationwide.
Quick answers
Who was awarded contract SPE2DB25FP6YZ?
SPE2DB25FP6YZ was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on June 3, 2025.
How much is contract SPE2DB25FP6YZ worth?
The government has obligated $1,989 on SPE2DB25FP6YZ.
Is contract SPE2DB25FP6YZ an order under another contract?
Yes. SPE2DB25FP6YZ is a delivery order under SPE2DB22D9311, an indefinite delivery contract.
Was contract SPE2DB25FP6YZ competed?
The extent of competition for SPE2DB25FP6YZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award